A major goal of the Immunology Core is to provide relevant immunologic assays and reagents for basic and clinical investigations of HIV and AIDS. This Core furthers understanding of the immunopathogenesis and pathogenesis of HIV infection and AIDS, provides new approaches toward understanding cellular and humoral responses to HIV, determines the effects of different anti-retroviral regimens on reconstitution of immunologic responses in HIV-infected subjects, determines the effects of immunotherapy or gene therapy on reconstitution of immunologic responses or on altering the clinical course in HIV-infected subjects receiving antiretroviral therapy, and develops HIV vaccine strategies. The Immunology Core (IC) offers a wide range of services to benefit all CFAR members performing H/V-related immunological research. Our services can be subdivided into two major groups: Self and Full Service. The self-service section of the Core prepares validated reagents and materials that are widely used among the member labs of the CFAR. These services include purification of primary human blood cells and antibody production, purification, labeling and enzymatic digestion. During the course of this application, the IC will create HIV-specific tetramer reagents. In addition, training is available for culture and transfection of primary cells, ELISA, and ELISPOT assays. The Full Service section will perform standard immunological assays using AACTG and PACTG approved protocols on samples provided by CFAR members. In addition, a number of flow cytometry-based assays including phenotyping, intracellular cytokine measurements and live sorting of both infectious and non-infectious materials can be performed by highly experienced technicians using the state-of-art equipment.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI045008-10
Application #
7650390
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2008-07-01
Project End
2009-06-30
Budget Start
2008-07-01
Budget End
2009-06-30
Support Year
10
Fiscal Year
2008
Total Cost
$254,956
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
MacBrayne, Christine E; Marks, Kristen M; Fierer, Daniel S et al. (2018) Effects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarate. J Antimicrob Chemother 73:2112-2119
Veenhuis, Rebecca T; Kwaa, Abena K; Garliss, Caroline C et al. (2018) Long-term remission despite clonal expansion of replication-competent HIV-1 isolates. JCI Insight 3:
Ecker, Christopher; Guo, Lili; Voicu, Stefana et al. (2018) Differential Reliance on Lipid Metabolism as a Salvage Pathway Underlies Functional Differences of T Cell Subsets in Poor Nutrient Environments. Cell Rep 23:741-755
Schnoll, Robert A; Thompson, Morgan; Serrano, Katrina et al. (2018) Rate of Nicotine Metabolism and Tobacco Use among Persons with HIV: Implications for Treatment and Research. J Acquir Immune Defic Syndr :
Loy, Dorothy E; Rubel, Meagan A; Avitto, Alexa N et al. (2018) Investigating zoonotic infection barriers to ape Plasmodium parasites using faecal DNA analysis. Int J Parasitol 48:531-542
Kendall, Jacob; Anglewicz, Philip (2018) Migration and health at older age in rural Malawi. Glob Public Health 13:1520-1532
Liu, Wei; Krump, Nathan A; MacDonald, Margo et al. (2018) Merkel Cell Polyomavirus Infection of Animal Dermal Fibroblasts. J Virol 92:
Plenderleith, Lindsey J; Liu, Weimin; MacLean, Oscar A et al. (2018) Adaptive Evolution of RH5 in Ape Plasmodium species of the Laverania Subgenus. MBio 9:
Colón, Krystal; Speicher, David W; Smith, Peter et al. (2018) S100a14 is Increased in Activated Nk Cells and Plasma of HIV-Exposed Seronegative People Who Inject Drugs and Promotes Monocyte-Nk crosstalk. J Acquir Immune Defic Syndr :
Sturgeon, Kathleen M; Hackley, Renata; Fornash, Anna et al. (2018) Strategic recruitment of an ethnically diverse cohort of overweight survivors of breast cancer with lymphedema. Cancer 124:95-104

Showing the most recent 10 out of 775 publications